Preclinical
Researchers at Sweden’s Lund University reported that a blood test can reveal whether there is accelerating nerve cell damage in the brain.
The two companies will combine their expertise to drive new immunology candidates toward the clinic.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Researchers at Yale University were able to restore basic cellular activity in the brains of pigs only hours after their deaths. They published their work in the journal Nature.
The vast majority of immune cells are found in the gut but historically, the gut has been viewed as a liability to drug development. The question of whether or not greater understanding of harnessing the gut could drive more promising drug development has led to the formation of a new company, Kintai Therapeutics.
There is a tendency to look at biotech as being all about developing drugs. And, of course, that is the primary focus of BioSpace. However, from time to time it’s a good idea to remind ourselves that biotech can and does have broader applications besides medicines, and can, in fact, impact our daily lives on a regular basis.
When the mice were dosed with ketamine, the effects of depression were reversed. Ketamine restored synapses in the brains of the mice.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
One of the many tricks the AIDS virus, HIV, uses to proliferate so aggressively is it hides from the body’s immune system. Until now, this has largely been a mystery.
Seattle-based Ambry Genetics recently presented data at the American College of Medical Genetics and Genomics annual meeting describing the results of supplemental RNA genetic testing data.
PRESS RELEASES